Clinical trial
Expression and Clinical Significance of IGHD in Pancreatic Cancer
NCT05327400 is registered in ClinicalTrials.gov with Affiliated Hospital of Nantong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Expression and Clinical Significance of IGHD in Pancreatic Cancer
- Lead sponsor
- Affiliated Hospital of Nantong University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 1, 2022
- Completion date
- October 31, 2023
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gene expression